GIM
BEAT

Granahan Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Granahan Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,570
Closed -$220K – 250
2017
Q2 		$220K Buy
+6,570
New +$196K 0.02% 218

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Granahan Investment Management's BEAT Position: Q3 2017 in Review

Granahan Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 6,570 shares — an estimated $220K sold.

Granahan Investment Management first reported a position in BEAT in Q2 2017 and held it in 1 quarter. The position peaked at $220K in Q2 2017. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

  • Granahan Investment Management reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
  • Granahan Investment Management sold 6,570 BioTelemetry, Inc. shares in Q3 2017, an estimated $220K.
  • Granahan Investment Management first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 1 quarter.
  • Granahan Investment Management's BioTelemetry, Inc. position peaked at $220K in Q2 2017.
  • 211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on Granahan Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.